key: cord-0281317-71siia0d authors: Barnes, K.; Faasse, K.; Colagiuri, B. title: The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample date: 2022-05-11 journal: nan DOI: 10.1101/2022.05.09.22274840 sha: 73bda12c6a85984cc12b2c8254678834986f47d9 doc_id: 281317 cord_uid: 71siia0d Objective: To evaluate the effect of presenting positively attribute-framed side effect information on COVID-19 booster vaccine intention relative to standard negatively-framed wording and a no-intervention control. Design setting and participants: A representative sample of Australian adults (N=1,204) were randomised to one of six conditions within a factorial design: Framing (Positive; Negative; Control) * Vaccine (Familiar (Pfizer); Unfamiliar (Moderna)). Intervention: Negative Framing involved presenting the likelihood of experiencing side effects (e.g., heart inflammation is very rare, 1 in every 80,000 will be affected), whereas Positive Framing involved presenting the same information but as the likelihood of not experiencing side effects (e.g., 79,999 in every 80,000 will not be affected). Primary Outcome: Booster vaccine intention measured pre- and post-intervention. Results: Positive Framing (M=75.7, SE=0.9, 95% CI[73.9, 77.4]) increased vaccine intention relative to Negative Framing (M=70.7, SE=0.9, 95% CI[68.9, 72.4]) overall (F(1, 1192)=4.68, p=.031, {eta}p2=.004). Framing interacted with Vaccine and Baseline Intention (F(2, 1192)=6.18, p=.002, {eta}p2=.01). Positive Framing was superior, or at least equal, to Negative Framing and Control at increasing Booster Intention, irrespective of the participants pre-intervention level of intent. Side effect worry and perceived severity mediated the effect of Positive vs. Negative Framing across vaccines. Conclusion: Positive framing of side effect information appears superior for increasing vaccine intent relative to the standard negative wording currently used. Pre-registration: See: aspredicted.org/LDX_2ZL Reasons for vaccine hesitancy are multifaceted 1,2 . However, side effect apprehension is a 48 primary factor 1 , with previous experience of COVID-19 vaccine side effects shown to reduce 49 later booster vaccine intention 3 . To achieve effective societal protection from COVID-19, 50 behavioural intervention is required to reduce apprehension and increase vaccine acceptance 4 . 51 Side effect information framing has been suggested as such an intervention 5 . Standard 52 negative wording is typically used to present side effect information on official sources such as 53 the Australian Government and AusVaxSafety (a national vaccine safety system) websites. For 54 example, "33% of people were affected by headaches after their second Pfizer dose". Our 55 research suggests negative wording of this type may increase hesitancy relative to positive 56 wording (i.e., presenting the number not affected) 6 . Further, consistent with prior research 57 demonstrating that vaccine relevance or familiarity moderates the effect of framing 7,8 , this effect 58 was especially pronounced when associated with an unfamiliar vaccine 6 . 59 Updating currently presented side effect information with a positively framed 60 counterpart is both easy to implement and does not violate patient informed consent (given that 61 statistical information is equivalent to the standard negative form) 9 . As such, framing may be 62 particularly well suited to increasing vaccine acceptance. However, in our previous research 63 conducted in a UK sample, framing was applied to side effect frequency bands presented in 64 manufacturer Patient Information Leaflets (PILs). This statistical information is commonly 65 presented in the EU, but not in Australia. 66 In the present study, we therefore tested an intervention more similar to current 67 Australian sources of side effect information (such as AusVaxSafety). Information detailing 68 severe side effects (heart inflammation and anaphylaxis 10,11 ) and side effect-induced daily 69 disruptions (data from AusVaxSafety) were presented to participants who had received two 70 doses of a COVID-19 vaccine but no booster. This information was presented using the 71 were performed in order to encourage participants to engage with and process the presented side 123 effect information. The primary components of the intervention occurred in stages 4 and 5. In 124 stage 4, participants viewed framed information (either positive or negative depending on group 125 assignment) in the form of infographics regarding 'daily disruptions' from side effects. In stage 126 5 this was also done regarding 'serious side effects' (estimates from 10,11 ). Stages 4 and 5 were 127 displayed for 30 seconds each. The exact order of presentation for stages 4 and 5 depended on 128 the participant's primary concern from stage 1. For example, if they indicated that they were 129 more concerned with 'daily disruptions' then that information was first presented at stage 4. 130 The information presented to the Positive and Negative framing groups differed only in 131 terms of whether this information stated the likelihood of experiencing or not experiencing the 132 described side effect. Those assigned to the Negative Framing group saw 'standard' wording 133 regarding side effects (e.g., Heart Inflammation: occurrence is very rare, 1 in every 80,000 will 134 be affected), while those in the Positive Framing group saw the logical inverse (e.g., occurrence 135 is very rare, 79,999 in every 80,000 will not be affected). Example infographics are displayed in 136 Figure 1 (all infographics presented in S1.4). Framed information was not presented to the 137 Control group. Instead, participants undertook an activity of their choosing for an equivalent 138 intervention duration (2 minutes). 139 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Prior to randomisation, all participants provided demographic information, as well as 147 vaccine and COVID-19 history (see Supporting Information (S1.3) for survey items). They also 148 completed baseline measures for the primary (Booster Intention) and secondary outcomes, 149 before being assigned to a condition. Please note, Baseline Intention was collected for both 150 vaccines (Pfizer and Moderna). Dependent on randomisation, one of these ratings became the 151 baseline for the framed vaccine, and the other the 'unassigned' vaccine (i.e., to explore 152 generalisation). 153 Following group assignment, framing information (positive or negative) regarding side-154 effect likelihood for the assigned vaccine was presented to those in the intervention groups. All 155 participants subsequently provided post-manipulation ratings for primary and secondary 156 outcomes. See Figure 2 We asked you to estimate the percentage of people in Australia experiencing six of the most common side effects to the Moderna vaccine. The graph below presents your personal estimates in orange against the actual data collected from the Australian population in blue. Please move your mouse over the data to explore the differences. Your data Severe allergic reaction (anaphylaxis) and heart inflammation (myocarditis and pericarditis) are two of the most serious side effects resulting from the Moderna vaccine, but the likelihood of experiencing them is very rare. There have been no deaths in Australia from either side effect. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Moderna). Dependent on randomisation, one became the baseline for the framed vaccine and 161 the other to explore generalisation of the framing effect (i.e., to unassigned vaccine). 162 Participants were stratified by previous vaccine and randomised to one of six groups (2*3 163 factorial design). Those receiving Positive or Negative Framing underwent a manipulation with 164 five stages: rating of primary concerns; active estimation of side effects; presentation of 165 estimated side effects against population data; framed information regarding daily disruptions; 166 framed information regarding serious side effects. Pre-registered analysis of all secondary 167 outcomes are presented as Supporting Information (S1.1). 168 Booster Intention Perceived Booster Protection Perceived Side Effect Severity Severe allergic reaction (anaphylaxis) and heart inflammation (myocarditis and pericarditis) are two of the most serious side effects resulting from the Moderna vaccine, but the likelihood of experiencing them is very rare. There have been no deaths in Australia from either side effect. 47% of people in Australia did not experience any side effects from their Moderna vaccines. 76% were able to continue with work, study, or routine duties. 98% did not need to seek the advice of a medical professional in the days after their vaccination. We asked you to estimate the percentage of people in Australia experiencing six of the most common side effects to the Moderna vaccine. The graph below presents your personal estimates in orange against the actual data collected from the Australian population in blue. Please move your mouse over the data to explore the differences. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) A total of 2,639 participants expressed interest. Of these, 998 did not meet inclusion 184 criteria, 3 terminated at consent, 296 withdrew before completion, and 138 were excluded on 185 pre-registered quality-control criteria (see S1.5). The final sample included 1,204 participants. 186 Demographic information, COVID-19 exposure and vaccination history can be found in 188 Table 1 . Participant frequency by SA4 postal region is presented in Figure 3 . 189 190 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 11, 2022. ; https://doi.org/10.1101/2022.05.09.22274840 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 11, 2022. underestimated side effects for the Modena (N=118) relative to Pfizer (N=65) vaccine (c 2 (1) = 204 18.97, p<.0001), due to the vaccine having a higher incidence of side effects than Pfizer. 205 Booster Intentions were higher for any Framing relative to Control (Contrast1: F(1, 207 1192 p=.031, ηp 2 =.004). As presented in Figure 4a , the anticipated Framing*Vaccine interaction was 210 not significant at Contrast2 (Positive vs. Negative: F(1, 1192) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 11, 2022. ; https://doi.org/10.1101/2022.05.09.22274840 doi: medRxiv preprint The present study tested an intervention involving the presentation of framed side-effect 249 information. Overall, providing side effect information of any type to participants increased 250 their COVID-19 Booster Intention relative to the Control group, who received no information at 251 all. Of note, Positive Framing further increased Booster Intention relative to Negative Framing 252 by 5 percentage points. While the mapping between intention and uptake is unlikely to be 253 exact 18 (see below), our results suggest that Positive Framing could lead to up to half a million 254 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. There are several strengths to the present study, including the framing of real COVID-19 296 vaccines and the use of actual side effect data presented to the Australian population. Especially 297 as much of the literature in this area frames fictitious vaccines and asks participants to imagine 298 scenarios that they have never experienced and may be unlikely to ever experience 7,8,12,17,20 . 299 Limitations of the study include the measurement of intention, but not uptake. While intention 300 has been found to predict vaccination 21-24 , longitudinal research is needed to directly assess the 301 role of framing on actual uptake, as well as the longevity of the framing effect among those yet 302 to receive a booster vaccine. Relevant to the lag in booster uptake in Australia 25 , the present 303 research focused on increasing intention among those already receiving a primary course of 304 COVID-19 vaccination. However, these results do not speak to the effect of framing on those 305 never vaccinated. Investigation of framing on vaccine intention at all points of the vaccination 306 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 11, 2022. ; https://doi.org/10.1101/2022.05.09.22274840 doi: medRxiv preprint programme would provide a more comprehensive account of the effect of framing on vaccine 307 intentions in general. 308 In summary, a brief online intervention engaging participants in side effect estimation 309 before presenting positively framed side effect information can increase booster vaccine 310 intention. Given the ease with which Positive Framing can be implemented, combined with the 311 fact that the presentation of statistical information in this format does not violate patient 312 informed consent 9 , the potential exists for framing of this type to make a real difference in 313 improving societal protection from COVID-19 through reduced vaccine hesitancy. 314 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 11, 2022. ; https://doi.org/10.1101/2022.05.09.22274840 doi: medRxiv preprint March. https://www.theguardian.com/australia-news/australia-395 datablog/2022/mar/17/tracking-australias-booster-rollout-data-shows-millions-of-396 eligible-australians-yet-to-get-third-covid-vaccine-dose (accessed March 2022). 397 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 11, 2022. ; https://doi.org/10.1101/2022.05.09.22274840 doi: medRxiv preprint COVID-19 vaccine acceptance and hesitancy in low-and middle Communicating risk of medication side effects An empirical evaluation of EU recommended terminology Research design and statistical analysis ANOVA for the behavioural sciences researcher All Frames Are Not Created Equal: A 368 Typology and Critical Analysis of Framing Effects Attribute Framing and Goal Framing Effects in 371 Intention-Behavior Relations: A Conceptual and Empirical Review Ten threats to global health in 2019 (World Health Organisation Framing of outcome and probability of 378 recurrence: Breast cancer patients' choice of adjuvant chemotherapy (ACT) in 379 hypothetical patient scenarios Predicting Human Papillomavirus Vaccine Uptake in 381 Young Adult Women: Comparing the Health Belief Model and Theory of Planned 382 Does Referring to Both Cervical Cancer and Genital Warts Affect Intended and Actual 385 Vaccination Behavior? Women's Health Issues The intention to get 387 vaccinated against influenza and actual vaccination uptake of Dutch healthcare 388 personnel Video-based messages to reduce COVID-19 390 vaccine hesitancy and nudge vaccination intentions Tracking Australia's booster rollout: data shows millions of eligible 393 Australians yet to get third Covid vaccine dose. The Guardian (Australia) 2022